Float Short %

23.9

Margin Of Safety %

Put/Call OI Ratio

0.12

EPS Next Q Diff

EPS Last/This Y

-0.02

EPS This/Next Y

0.55

Price

1.86

Target Price

Analyst Recom

Performance Q

-19.48

Relative Volume

0.61

Beta

-2.07

Ticker: SAVA

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	SAVA	1.33	0.14	0.03	104546
2025-04-15	SAVA	1.43	0.13	0.07	105310
2025-04-16	SAVA	1.42	0.13	0.15	105872
2025-04-17	SAVA	1.44	0.13	0.03	106186
2025-04-18	SAVA	1.44	0.13	0.04	106186
2025-04-21	SAVA	1.465	0.14	0.05	90946
2025-04-22	SAVA	1.59	0.14	0.02	90099
2025-04-23	SAVA	1.655	0.13	0.08	91454
2025-04-24	SAVA	1.655	0.13	0.06	92419
2025-04-25	SAVA	1.57	0.13064876408356	0.38729198184569	92123
2025-04-28	SAVA	1.59	0.13317130927899	0.16573348264278	90920
2025-04-29	SAVA	1.565	0.13	0.02	91595
2025-04-30	SAVA	1.56	0.13	0.02	91566
2025-05-01	SAVA	1.625	0.13	0.08	91589
2025-05-02	SAVA	1.61	0.13	0.07	91796
2025-05-05	SAVA	1.595	0.13	0.08	90161
2025-05-06	SAVA	1.505	0.13	0.06	90506
2025-05-07	SAVA	1.555	0.13	0.10	90995
2025-05-08	SAVA	1.7	0.12	0.10	91685
2025-05-09	SAVA	1.78	0.12	0.24	93144
2025-05-12	SAVA	1.825	0.12	0.46	93102
2025-05-13	SAVA	1.86	0.12	0.19	93383
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	SAVA	1.34	-	-	-0.55
2025-04-15	SAVA	1.43	-	-	-0.55
2025-04-16	SAVA	1.42	-	-	-0.55
2025-04-17	SAVA	1.44	-	-	-0.55
2025-04-18	SAVA	1.44	-	-	-0.55
2025-04-21	SAVA	1.46	-	-	-0.55
2025-04-22	SAVA	1.59	-	-	-0.55
2025-04-23	SAVA	1.66	-	-	-0.55
2025-04-24	SAVA	1.65	-	-	-0.55
2025-04-25	SAVA	1.57	-	-	-0.55
2025-04-28	SAVA	1.59	-	-	-0.55
2025-04-29	SAVA	1.56	-	-	-0.55
2025-04-30	SAVA	1.56	-	-	-0.55
2025-05-01	SAVA	1.62	-	-	-0.55
2025-05-02	SAVA	1.61	-	-	-0.55
2025-05-05	SAVA	1.60	-	-	-0.55
2025-05-06	SAVA	1.50	-	-	-0.55
2025-05-07	SAVA	1.56	-	-	-0.55
2025-05-08	SAVA	1.70	-	-	-0.55
2025-05-09	SAVA	1.77	-	-	-0.55
2025-05-12	SAVA	1.83	-	-	-0.55
2025-05-13	SAVA	1.86	-	-	-0.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	SAVA	-1.03	21.99	26.56
2025-04-15	SAVA	-1.03	21.99	26.56
2025-04-16	SAVA	-1.03	21.99	26.56
2025-04-17	SAVA	-1.03	21.99	26.56
2025-04-18	SAVA	-1.03	21.99	26.56
2025-04-21	SAVA	-1.03	22.59	26.56
2025-04-22	SAVA	-1.03	22.59	26.56
2025-04-23	SAVA	-1.03	22.59	26.56
2025-04-24	SAVA	-1.03	22.59	26.56
2025-04-25	SAVA	-1.03	22.59	26.56
2025-04-28	SAVA	-1.03	22.23	26.43
2025-04-29	SAVA	-1.03	22.23	26.43
2025-04-30	SAVA	-1.03	22.23	26.43
2025-05-01	SAVA	-1.03	22.23	26.43
2025-05-02	SAVA	-1.03	22.23	26.43
2025-05-05	SAVA	-1.03	21.31	26.43
2025-05-06	SAVA	-1.03	21.31	26.43
2025-05-07	SAVA	-1.03	21.31	26.43
2025-05-08	SAVA	-1.03	21.31	26.43
2025-05-09	SAVA	-1.03	21.31	26.43
2025-05-12	SAVA	-1.03	18.09	23.90
2025-05-13	SAVA	-1.03	18.09	23.90
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.68

Avg. EPS Est. Next Quarter

Insider Transactions

-1.03

Institutional Transactions

18.09

Beta

-2.07

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.7

Max Drawdown 5-Year %

-99.1

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.7

P/Free Cash Flow

EPS

-1.51

Average EPS Est. Cur. Y

-0.55

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.61

Return on Equity vs Sector %

-80.7

Return on Equity vs Industry %

-63.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.07

EBIT Estimation

Cassava Sciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 30

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

stock quote shares SAVA – Cassava Sciences, Inc. Stock Price stock today

news today SAVA – Cassava Sciences, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SAVA – Cassava Sciences, Inc. yahoo finance google finance

stock history SAVA – Cassava Sciences, Inc. invest stock market

stock prices SAVA premarket after hours

ticker SAVA fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SAVA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y